How many insider declarations has Levy Adam D. filed?

Levy Adam D. has filed 3 public insider declarations with SEC (Form 4).

What is Levy Adam D.'s role?

Levy Adam D.'s reported role is not specified by the regulator across the filings.

Which companies does Levy Adam D. report trades for?

Levy Adam D. reports trades for Acrivon Therapeutics, Inc..

What is Levy Adam D.'s declared buy vs sell volume?

Across the available history, declared buys total 13k€ and disposals 2k€.

← Executives ★ Sign in to follow

LA

Levy Adam D.

CFO

·SEC (Form 4)

Acrivon Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

€12,883

▲ Purchases (1 ops.)

€1,557

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

1

T+90 hit rate

0%

T+90 mean return

-6.8%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the full record of transactions filed by Levy Adam D.. Officer active across 1 company, notably Acrivon Therapeutics, Inc.. In total, 3 reports have been logged. Split: 1 buy · 1 sell. Total volume traded: €14k. Activity tracked since 1 August 2025. The latest transaction was disclosed on 4 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Levy Adam D.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Acrivon Therapeutics, Inc. (US)

Declarations3 total

▼

Levy Adam D.

Chief Financial OfficerExecutives4 Aug 2026Acrivon Therapeutics, Inc.

$1,7930SEC ↗

1,142 shares@ US$1.57Common StockSEC:0000905148-26-003499:0

▲

Levy Adam D.

Chief Financial OfficerExecutives14 Jan 2026Acrivon Therapeutics, Inc.

$14,99946SEC ↗

8,832 shares@ US$1.698390.9% of flowCommon StockSEC:0000905148-26-000225:0

Canonical exit: 14 Apr 2026 (T+90)

●

Levy Adam D.

Chief Financial OfficerExecutives1 Aug 2025Acrivon Therapeutics, Inc.

$1,46727SEC ↗

1,164 shares@ US$1.26100.0% of flowCommon StockSEC:0000905148-25-002732:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

LA

Levy Adam D.

CFO

·SEC (Form 4)

Acrivon Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

€12,883

▲ Purchases (1 ops.)

€1,557

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

1

T+90 hit rate

0%

T+90 mean return

-6.8%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the full record of transactions filed by Levy Adam D.. Officer active across 1 company, notably Acrivon Therapeutics, Inc.. In total, 3 reports have been logged. Split: 1 buy · 1 sell. Total volume traded: €14k. Activity tracked since 1 August 2025. The latest transaction was disclosed on 4 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.